<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> postconditioning has been proven to protect the hearts against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury, manifested mainly by improved cardiac function, reduced myocardial specific biomarker release, and decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="1" pm="."><plain>This study is to observe the effects of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning on reperfusion-induced <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and reactive oxygen species generation in Langendorff perfused rat hearts </plain></SENT>
<SENT sid="2" pm="."><plain>Compared with the unprotected hearts subjected to 25 min of global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> followed by 30 min of reperfusion, exposure of 3% <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> during the first 15 min of reperfusion significantly improved cardiac function, reduced cardiac troponin I release, decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> size and attenuated reperfusion-induced <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Further analysis on <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> during the 30 min of reperfusion showed that, <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning decreased both the duration and incidence of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> and <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In the meantime, intracellular malondialdehyde and reactive oxygen species levels were also reduced </plain></SENT>
<SENT sid="5" pm="."><plain>These above results demonstrate that <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning protects the hearts against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury and attenuates reperfusion-induced <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>, which may be associated with the regulation of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and reactive oxygen species generation </plain></SENT>
</text></document>